Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

How common is cholesterol embolism?

S S Cross1

  • 1Department of Pathology, University of Sheffield Medical School.

Journal of Clinical Pathology
|October 1, 1991
PubMed
Summary
This summary is machine-generated.

Cholesterol emboli were found in 2.4% of necropsies, primarily in older males. This incidence may be lower than previously reported, with clinical relevance dependent on patient history.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcome of elective withdrawal of anti-tumour necrosis factor-α therapy in patients with Crohn's disease in established remission.

Journal of Crohn's & colitis·2014
Same author

Nuclear targeting of dystroglycan promotes the expression of androgen regulated transcription factors in prostate cancer.

Scientific reports·2013
Same author

Dystroglycan function is a novel determinant of tumor growth and behavior in prostate cancer.

The Prostate·2012
Same author

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.

British journal of cancer·2012
Same author

Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.

British journal of cancer·2011
Same author

Blood vessel characterization in human dermal wound repair and scarring.

The British journal of dermatology·2011
Same journal

Defining biochemical, pathological and molecular factors prognostic in terms of disease control and survival in high-grade extremity soft tissue sarcoma: a scoping review.

Journal of clinical pathology·2026
Same journal

MILGDF: a multi-task, instance-level supervised model for oral squamous cell carcinoma integrating local-global attention and dynamic decision fusion.

Journal of clinical pathology·2026
Same journal

Paediatric B-lymphoblastic leukaemia with low peripheral blasts: a potential diagnostic pitfall.

Journal of clinical pathology·2026
Same journal

MRI-targeted versus systematic needle core biopsies in prostate cancer: a patient-based analysis of potential diagnostic and biologic underestimation.

Journal of clinical pathology·2026
Same journal

Basal plasmacytosis and eosinophilia for distinguishing inflammatory bowel disease from gastrointestinal tuberculosis on mucosal biopsy.

Journal of clinical pathology·2026
Same journal

Assay-dependent variability in free thyroxine (FT4): differential interference related to immunoassay design in a patient with subclinical hypothyroidism.

Journal of clinical pathology·2026
See all related articles

Area of Science:

  • Pathology
  • Nephrology
  • Cardiovascular Science

Background:

  • Cholesterol embolism is a recognized complication of atherosclerosis and invasive vascular procedures.
  • Previous studies suggest a higher incidence in North America compared to other regions.
  • The prevalence and clinical significance of cholesterol embolism in British populations require further elucidation.

Purpose of the Study:

  • To determine the incidence of cholesterol emboli in a British necropsy cohort.
  • To investigate the demographic and clinical characteristics of individuals with cholesterol emboli.
  • To assess the potential correlation between cholesterol embolism and cause of death.

Main Methods:

  • Histological examination of spleen and kidney sections from 372 necropsies.

Related Experiment Videos

  • Review of clinical histories for cases with identified cholesterol emboli.
  • Calculation of incidence rates, differentiating between procedure-related and spontaneous embolism.

    • Main Results:

    • Cholesterol emboli were identified in 9 out of 372 cases (2.4%).
    • Affected individuals were predominantly older males (>60 years).
    • Recurrent embolism suggested by lesions of differing ages; spontaneous embolism incidence was 1.9% after excluding recent arteriography cases.

    Conclusions:

    • The observed incidence of cholesterol embolism in this British cohort is lower than reported in some previous studies.
    • Cholesterol embolism may be recurrent and its clinical relevance is best assessed with comprehensive clinical data.
    • Further research is needed to understand geographical and temporal variations in cholesterol embolism incidence.